Our Services
Precision healthcare at your fingertips
We are redefining healthcare through intelligent, data-driven, patient-centric solutions — integrating AI-powered diagnostics, personalised medicine, signature microRNA drug treatments and meaningful health insights.
AI-powered diagnosis & treatment recommendations
Our platform analyses a patient’s health data with AI, helping doctors save time, reduce errors, and deliver more accurate care. With real-time insights, providers make decisions on comprehensive data, with treatment plans personalised to each patient.
Cancer, heart, rare & genetic diseases
At the forefront of microRNA technology, we create highly personalised treatments tailored to each patient’s unique genetic profile — targeting the root cause of cancer, heart disease and rare genetic disorders, with fewer side effects.
Health data analytics
Respecting personal data under GDPR, we process everything from medical histories to lab reports so doctors and patients make better-informed decisions — from the best course of action to tracking health progress.
Cost-effective treatment plans
We work directly with pharmaceutical companies and providers to offer affordable options. By leveraging AI and analytics, we make life-saving treatments more accessible — so everyone has the opportunity to get the care they need.
See CureLogic in action
Why standardised dosing falls short
Drug treatment dosages are often standardised using weight, surface area, and gender — but not yet focused on pharmacodynamics or disease progression. This leads to dosage issues, increased costs, and higher mortality rates.
Side effects that increase hospital-bed use by ~15%
~$30 billion extra in the USA and £3 billion in the UK
~5% of additional hospital visits across the USA, UK and EU
More non-responsive patients, delayed treatments, and deaths
Greater discomfort for patients
Disease is personal — treatment should be too
Disease progression depends on individual genetic, proteomic and environmental factors, each needing different dosages and therapeutics as it progresses. Precision medicine makes dosages relevant to the specific patient through large-scale data analysis; personalised medicine uses the patient’s genetic profile to treat the disease more effectively.
The promise of personalised treatment requires a huge expansion of the repository drug arsenal.
Drug arsenal today
~8,000–20,000
Known diseases
~35,000
Needed for progression levels
~100,000
One integrated platform, one-stop solution
CureLogic AI is an integrated Platform-as-a-Service that combines all our services into a one-stop solution for personalised medicine. It couples our proprietary technology with a CRISPR platform running on a supercomputer that validates the proposed microRNA signature drug-treatment plan on the patient’s own cells — achieving rapid turnover capable of performing the tasks within 2–3 weeks.
CureLogic AI — PaaS
Addressed to:
Cancer patients / hospital / yr
Heart-disease patients / yr
Genetic diseases / yr
Our price / IM injection
Monthly PaaS licence
Projected / yr · 10 hospitals
Current treatment pricing runs €196,000–€446,000 per patient. We intend to price near €18,000 and extend treatments to the less fortunate — assuming just 1% of patients sign the waiver for experimental drug treatment across Asia, Africa and South America.
Annual revenues at 1% of market
Freemium & 6-month PaaS licensing
Revenue
€1.375M
Market
50 hospitals, clinics, universities
Treatment plans
Revenue
€0M
Market
Pre-approval
CURE advanced payment plans
Revenue
€1.08M
Market
60 insurers / individuals / hospitals
Precision medicine is a global market
The precision-medicine market was valued at €78.85B in 2021 and is projected to reach €278B by 2028 — a steady 12.5% annual growth from 2024 onward.
Market value · 2021
Projected · 2028
Annual growth
Financial projections for CureLogic
| Summary | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Total income | €2,455,000 | €94,870,500 | €105,182,550 |
| Total outgoings | €2,656,830 | €6,001,404 | €5,868,726 |
| Net profit / loss | -€201,830 | €88,869,096 | €99,313,824 |
Precision-driven care. Personalised for every life.
Whether you’re here to collaborate, innovate, or invest in the future of precision medicine — we’re ready to move forward, together.